CATX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.52%

Insider Buying (Last 12 Months): $642,275.37

Insider Selling (Last 12 Months): $0.00

Perspective Therapeutics Insider Trading History Chart

Perspective Therapeutics Share Price & Price History

^$2.20

▼ -0.1 (-4.35%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

Perspective Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/4/2024	Heidi Henson	Director	Buy	25,975	$3.85	$100,003.75	25,975
12/4/2024	Johan M Spoor	CEO	Buy	8,000	$3.77	$30,160.00	36,257
11/25/2024	Johan M Spoor	CEO	Buy	14,500	$3.78	$54,810.00	152,072
11/25/2024	Jonathan Robert Hunt	CFO	Buy	12,829	$3.82	$49,006.78	48,800
11/25/2024	Robert F Williamson III	Director	Buy	6,266	$3.64	$22,808.24	430,058
6/17/2024	Jonathan Robert Hunt	CFO	Buy	1,800	$9.81	$17,658.00	35,971
6/14/2024	Lori A Woods	Director	Buy	4,587	$10.90	$49,998.30	159,985
6/13/2024	Johan M Spoor	CEO	Buy	10,000	$11.70	$117,000.00	13,757
6/3/2024	Lori A Woods	Director	Buy	3,424	$14.60	$49,990.40	155,398
5/31/2024	Jonathan Robert Hunt	CFO	Buy	2,500	$14.00	$35,000.00	34,171
5/31/2024	Robert F Williamson III	Director	Buy	5,500	$13.80	$75,900.00	42,379
5/29/2024	Robert F Williamson III	Director	Buy	3,003	$13.30	$39,939.90	36,879
3/6/2024	Lantheus Alpha Therapy, Llc	Major Shareholder	Buy	6,043,103	$9.50	$57,409,478.50	11,677,339
1/29/2024	Robert F Williamson III	Director	Buy	2,526	$6.40	$16,166.40	21,155
1/25/2024	Robert F Williamson III	Director	Buy	2,213	$4.90	$10,843.70	7,567
1/24/2024	Markus Puhlmann	Insider	Buy	28,000	$5.00	$140,000.00	137,542
12/21/2023	Robert F Williamson III	Director	Buy	366	$3.30	$1,207.80	366
12/18/2023	Jonathan Robert Hunt	CFO	Buy	12,500	$2.60	$32,500.00	31,671
12/18/2023	Markus Puhlmann	Insider	Buy	6,041	$2.60	$15,706.60	69,542
12/18/2023	Robert F Williamson III	Director	Buy	1,000	$2.60	$2,600.00	1,000
12/15/2023	Markus Puhlmann	Insider	Buy	13,500	$2.70	$36,450.00	63,500

See Full Table

SEC Filings (Institutional Ownership Changes) for Perspective Therapeutics (NYSE:CATX)

54.66% of Perspective Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Perspective Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	70,150	$0.22M	0.0%	+19.6%	0.104%
2/17/2025	Velan Capital Investment Management LP	500,000	$1.60M	1.4%	N/A	0.740%
2/17/2025	Squarepoint Ops LLC	196,208	$0.63M	0.0%	N/A	0.290%
2/17/2025	Wexford Capital LP	20,000	$64K	0.0%	N/A	0.030%
2/17/2025	Two Sigma Advisers LP	151,610	$0.48M	0.0%	N/A	0.224%
2/17/2025	Two Sigma Investments LP	650,351	$2.08M	0.0%	N/A	0.962%
2/17/2025	Sherbrooke Park Advisers LLC	21,564	$69K	0.0%	N/A	0.032%
2/17/2025	Sphera Funds Management LTD.	460,247	$1.47M	0.3%	-21.9%	0.681%
2/17/2025	Point72 Asset Management L.P.	54,893	$0.18M	0.0%	N/A	0.081%
2/17/2025	ProShare Advisors LLC	15,225	$49K	0.0%	+49.1%	0.023%
2/17/2025	Nuveen Asset Management LLC	722,048	$2.30M	0.0%	-13.0%	1.068%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	123,243	$0.39M	0.0%	+73.8%	0.182%
2/17/2025	Octagon Capital Advisors LP	2,304,752	$7.35M	1.2%	+62.1%	3.410%
2/17/2025	Millennium Management LLC	1,295,343	$4.13M	0.0%	N/A	1.916%
2/17/2025	Janus Henderson Group PLC	17,839	$57K	0.0%	-99.6%	0.026%
2/17/2025	Deutsche Bank AG	46,579	$0.15M	0.0%	+76.0%	0.069%
2/17/2025	DAFNA Capital Management LLC	130,169	$0.42M	0.1%	-43.5%	0.193%
2/17/2025	Deerfield Management Company L.P. Series C	2,938,754	$9.38M	0.2%	+4.3%	4.348%
2/17/2025	Corton Capital Inc.	19,180	$61K	0.0%	N/A	0.028%
2/17/2025	Cubist Systematic Strategies LLC	261,474	$0.83M	0.0%	N/A	0.387%
2/17/2025	Balyasny Asset Management L.P.	130,914	$0.42M	0.0%	N/A	0.194%
2/17/2025	Bank of America Corp DE	48,777	$0.16M	0.0%	-72.0%	0.072%
2/17/2025	BNP Paribas Financial Markets	51,094	$0.16M	0.0%	+7.4%	0.076%
2/17/2025	Ameriprise Financial Inc.	17,326	$55K	0.0%	-97.4%	0.026%
2/14/2025	Mercer Global Advisors Inc. ADV	16,088	$51K	0.0%	N/A	0.024%
2/14/2025	Freestone Grove Partners LP	47,386	$0.15M	0.0%	N/A	0.070%
2/14/2025	Schonfeld Strategic Advisors LLC	168,500	$0.54M	0.0%	-71.5%	0.249%
2/14/2025	Northern Trust Corp	487,273	$1.55M	0.0%	+2.8%	0.721%
2/14/2025	Tudor Investment Corp ET AL	28,577	$91K	0.0%	N/A	0.042%
2/14/2025	Aquatic Capital Management LLC	32,718	$0.10M	0.0%	N/A	0.048%
2/14/2025	Virtus ETF Advisers LLC	20,487	$65K	0.0%	+157.9%	0.030%
2/14/2025	Nebula Research & Development LLC	21,850	$70K	0.0%	+47.2%	0.032%
2/14/2025	Rock Springs Capital Management LP	444,383	$1.42M	0.1%	+7.2%	0.657%
2/14/2025	MetLife Investment Management LLC	22,228	$71K	0.0%	-28.7%	0.033%
2/14/2025	Altium Capital Management LLC	92,224	$0.29M	0.1%	-68.2%	0.136%
2/13/2025	Marshall Wace LLP	807,172	$2.58M	0.0%	-45.9%	1.194%
2/13/2025	Affinity Asset Advisors LLC	1,300,000	$4.15M	0.6%	+160.0%	1.923%
2/13/2025	Jump Financial LLC	215,725	$0.69M	0.0%	N/A	0.319%
2/13/2025	Walleye Capital LLC	475,792	$1.52M	0.0%	+2,526.2%	0.704%
2/13/2025	XTX Topco Ltd	18,070	$58K	0.0%	-51.6%	0.027%
2/13/2025	Mariner LLC	46,900	$0.15M	0.0%	N/A	0.069%
2/13/2025	Barclays PLC	94,879	$0.30M	0.0%	-16.8%	0.140%
2/13/2025	Legal & General Group Plc	48,538	$0.16M	0.0%	-13.5%	0.072%
2/13/2025	Aristides Capital LLC	58,700	$0.19M	0.0%	N/A	0.087%
2/13/2025	Wells Fargo & Company MN	26,462	$84K	0.0%	+45.7%	0.039%
2/12/2025	National Bank of Canada FI	11,000	$35K	0.0%	+549,900.0%	0.016%
2/12/2025	Arrowstreet Capital Limited Partnership	36,752	$0.12M	0.0%	-64.1%	0.054%
2/12/2025	JPMorgan Chase & Co.	149,045	$0.48M	0.0%	+498.3%	0.221%
2/11/2025	KLP Kapitalforvaltning AS	24,769	$79K	0.0%	N/A	0.037%
2/10/2025	Swiss National Bank	86,260	$0.28M	0.0%	-6.4%	0.128%
2/7/2025	HighTower Advisors LLC	178,111	$0.57M	0.0%	+26.1%	0.264%
2/7/2025	Citizens Financial Group Inc. RI	50,000	$0.16M	0.0%	N/A	0.074%
2/7/2025	AMG National Trust Bank	29,980	$92K	0.0%	-19.7%	0.044%
2/6/2025	Aigen Investment Management LP	10,522	$34K	0.0%	N/A	0.016%
2/6/2025	Charles Schwab Investment Management Inc.	406,966	$1.30M	0.0%	-6.1%	0.602%
2/4/2025	Bank of New York Mellon Corp	143,469	$0.46M	0.0%	+3.4%	0.212%
2/4/2025	Y Intercept Hong Kong Ltd	10,263	$33K	0.0%	N/A	0.015%
2/3/2025	Nicholson Wealth Management Group LLC	1,609,283	$5.13M	3.4%	+0.4%	2.381%
1/30/2025	WealthPlan Investment Management LLC	401,049	$1.28M	0.1%	+18.2%	0.593%
1/30/2025	Rhumbline Advisers	94,992	$0.30M	0.0%	+4.5%	0.141%
1/30/2025	Vontobel Holding Ltd.	16,000	$51K	0.0%	N/A	0.024%
1/23/2025	Koa Wealth Management LLC	25,975	$83K	0.1%	N/A	0.038%
1/22/2025	Wealth Effects LLC	38,000	$0.12M	0.0%	+186.8%	0.056%
1/17/2025	SG Americas Securities LLC	26,088	$83K	0.0%	+41.3%	0.039%
1/16/2025	Trueblood Wealth Management LLC	22,236	$71K	0.0%	+37.0%	0.033%
1/15/2025	Taylor & Morgan Wealth Management LLC	56,000	$0.18M	0.1%	+86.7%	0.083%
12/26/2024	JPMorgan Chase & Co.	24,912	$0.33M	0.0%	+24.1%	0.037%
11/19/2024	Barclays PLC	114,075	$1.52M	0.0%	+587.9%	0.169%
11/18/2024	JDM Financial Group LLC	3,500	$47K	0.0%	-90.0%	0.005%
11/16/2024	Geode Capital Management LLC	1,164,204	$15.55M	0.0%	+12.5%	1.722%
11/15/2024	Barclays PLC	114,075	$1.52M	0.0%	+587.9%	0.169%
11/15/2024	XTX Topco Ltd	37,300	$0.50M	0.0%	N/A	0.055%
11/15/2024	Jane Street Group LLC	25,256	$0.34M	0.0%	-67.9%	0.037%
11/15/2024	Sphera Funds Management LTD.	589,295	$7.87M	1.3%	-25.1%	0.872%
11/15/2024	State Street Corp	2,190,239	$29.24M	0.0%	+119.6%	3.240%
11/15/2024	Janus Henderson Group PLC	4,799,352	$64.01M	0.0%	+8.0%	7.101%
11/15/2024	HighVista Strategies LLC	138,350	$1.85M	0.6%	+21.8%	0.205%
11/14/2024	Verition Fund Management LLC	28,723	$0.38M	0.0%	N/A	0.043%
11/14/2024	Walleye Capital LLC	18,117	$0.24M	0.0%	-96.5%	0.027%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	58,678	$0.78M	0.0%	+5.8%	0.087%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	11,378	$0.15M	0.0%	N/A	0.017%
11/14/2024	Ally Bridge Group NY LLC	341,739	$4.56M	2.4%	-13.8%	0.507%
11/14/2024	MetLife Investment Management LLC	31,165	$0.42M	0.0%	+159.1%	0.046%
11/13/2024	BNP Paribas Financial Markets	47,565	$0.64M	0.0%	+1,302.7%	0.071%
11/13/2024	FMR LLC	5,504,822	$73.49M	0.0%	+3,994.9%	8.164%
11/13/2024	The Manufacturers Life Insurance Company	20,514	$0.27M	0.0%	+8.9%	0.030%
11/12/2024	Eagle Asset Management Inc.	181,467	$2.42M	0.0%	-24.9%	0.269%
11/12/2024	Charles Schwab Investment Management Inc.	433,522	$5.79M	0.0%	+221.7%	0.643%
11/9/2024	Intech Investment Management LLC	10,289	$0.14M	0.0%	N/A	0.015%
11/7/2024	LMR Partners LLP	30,000	$0.40M	0.0%	N/A	0.044%
11/6/2024	RIA Advisory Group LLC	25,620	$0.34M	0.1%	N/A	0.038%
11/6/2024	CIBC Asset Management Inc	19,415	$0.26M	0.0%	N/A	0.029%
11/5/2024	Victory Capital Management Inc.	50,460	$0.67M	0.0%	+328.7%	0.075%
11/5/2024	WealthPlan Investment Management LLC	339,292	$4.53M	0.5%	N/A	0.503%
11/4/2024	Los Angeles Capital Management LLC	11,424	$0.15M	0.0%	N/A	0.017%
10/30/2024	AlphaCentric Advisors LLC	80,000	$1.07M	0.8%	-2.4%	0.128%
10/28/2024	Hills Bank & Trust Co	1,027,830	$13.72M	1.0%	N/A	1.651%
10/28/2024	US Bancorp DE	6,576	$88K	0.0%	+142.7%	0.011%
10/24/2024	Taylor & Morgan Wealth Management LLC	30,000	$0.40M	0.3%	N/A	0.048%
10/23/2024	Trueblood Wealth Management LLC	16,236	$0.22M	0.1%	N/A	0.026%

Data available starting January 2016

See Full Table

Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. The company discovers, designs, and develop its initial programs candidates consists of VMT-a-NET, that is currently in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2) expressing tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta-emitting therapy; and VMT01, which is currently in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma. Perspective Therapeutics, Inc. has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Today's Range

Now: $2.20

$2.19

$2.37

50 Day Range

MA: $2.94

$2.20

$4.01

52 Week Range

Now: $2.20

$2.18

$19.05

Volume

657,194 shs

Average Volume

995,872 shs

Market Capitalization

$148.69 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25

Who are the company insiders with the largest holdings of Perspective Therapeutics?: Perspective Therapeutics' top insider shareholders include:
Lantheus Alpha Therapy, Llc (Major Shareholder)
Robert F Williamson III (Director)
Lori A Woods (Director)
Johan M Spoor (CEO)
Markus Puhlmann (Insider)
Jonathan Robert Hunt (CFO)
Heidi Henson (Director)
Learn More about top insider investors at Perspective Therapeutics.
Who are the major institutional investors of Perspective Therapeutics?: Perspective Therapeutics' top institutional investors include:
Deerfield Management Company L.P. Series C — 4.35%
Octagon Capital Advisors LP — 3.41%
Nicholson Wealth Management Group LLC — 2.38%
Affinity Asset Advisors LLC — 1.92%
Millennium Management LLC — 1.92%
Marshall Wace LLP — 1.19%
Learn More about top institutional investors of Perspective Therapeutics stock.
Which major investors are selling Perspective Therapeutics stock?: Within the previous quarter, CATX stock was sold by these institutional investors:
Janus Henderson Group PLC
Marshall Wace LLP
Ameriprise Financial Inc.
Schonfeld Strategic Advisors LLC
Altium Capital Management LLC
Sphera Funds Management LTD.
Bank of America Corp DE
Nuveen Asset Management LLC
Which major investors are buying Perspective Therapeutics stock?: Within the previous quarter, CATX stock was acquired by institutional investors including:
Millennium Management LLC
Octagon Capital Advisors LP
Affinity Asset Advisors LLC
Two Sigma Investments LP
Velan Capital Investment Management LP
Walleye Capital LLC
Cubist Systematic Strategies LLC
Jump Financial LLC
Within the previous year, these company insiders have bought Perspective Therapeutics stock:
Lantheus Alpha Therapy, Llc (Major Shareholder)
Robert F Williamson III (Director)
Lori A Woods (Director)
Johan M Spoor (CEO)
Markus Puhlmann (Insider)
Jonathan Robert Hunt (CFO)
Heidi Henson (Director)
Learn More investors buying Perspective Therapeutics stock.